Levofloxacin Sanovel (Levofloxacin)

Levofloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. By inhibiting these enzymes, the drug prevents bacterial DNA from unwinding and re‑joining, leading to halted cell division and bacterial death. This mechanism provides broad‑spectrum bactericidal activity.

The specific dose of Levofloxacin Sanovel is determined by the prescribing clinician based on the infection type, severity, patient age, renal function, and other clinical factors. Healthcare professionals follow approved guidelines and adjust the regimen as needed for optimal efficacy and safety.

Safety data for levofloxacin in pregnancy and lactation are limited, and the drug is generally avoided unless the potential benefit outweighs the risk. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives with their healthcare provider.

To request Levofloxacin Sanovel, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Levofloxacin belongs to the fluoroquinolone class, offering once‑daily oral dosing and broad coverage against Gram‑negative and many Gram‑positive organisms. Compared with beta‑lactams, it often provides faster symptom relief and convenient dosing but carries specific safety considerations such as tendon toxicity and QT prolongation, which may influence drug choice.

Levofloxacin Sanovel should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

Levofloxacin Sanovel is supplied for oral administration. The tablet or capsule is swallowed whole with a full glass of water, preferably on an empty stomach unless instructed otherwise by a healthcare professional. Patients should follow the prescriber’s directions regarding timing and food intake.

Serious adverse events include tendon rupture or tendinitis, QT interval prolongation leading to potentially life‑threatening arrhythmias, severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome, and Clostridioides difficile‑associated diarrhea. Patients should seek immediate medical attention if they experience unexplained tendon pain, palpitations, or severe skin reactions.

Levofloxacin Sanovel is contraindicated in individuals with a known hypersensitivity to levofloxacin or other fluoroquinolones. It should be avoided in patients with a history of tendon disorders related to fluoroquinolone use, those with significant QT prolongation, and patients receiving concomitant medications that strongly prolong the QT interval unless benefits clearly outweigh risks.